Cohort profile: design and methods of the Chinese colorectal, breast, lung, liver, and stomach cancer screening trial (C-BLAST)

References

1. 1.↵
   2. Maomao C,
   3. He L,
   4. Dianqin S,
   5. Siyi H,
   6. Xinxin Y,
   7. Fan Y, et al.

   Current cancer burden in China: epidemiology, etiology, and prevention. Cancer Biol Med. 2022; 19: 1121–38.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   2. Li X,
   3. Zhang S,
   4. Zhang Q,
   5. Wei X,
   6. Pan Y,
   7. Zhao J, et al.

   Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study. Lancet Oncol. 2019; 20: 193–201.

   OpenUrlCrossRefPubMed
3. 3.
   2. Rashkin SR,
   3. Graff RE,
   4. Kachuri L,
   5. Thai KK,
   6. Alexeeff SE,
   7. Blatchins MA, et al.

   Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020; 11: 4423.

   OpenUrl
4. 4.↵
   2. Liu MC,
   3. Oxnard GR,
   4. Klein EA,
   5. Swanton C,
   6. Seiden MV.

   Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020; 31: 745–59.

   OpenUrlPubMed
5. 5.↵
   2. Zhang Q,
   3. Zhang S,
   4. Li J,
   5. Pan Y,
   6. Zhao J,
   7. Feng Y, et al.

   Improved diagnosis of thyroid cancer aided with deep learning applied to sonographic text reports: a retrospective, multi-cohort, diagnostic study. Cancer Biol Med. 2021; 19: 733–41.

   OpenUrl
6. 6.↵
   2. Phillips MR,
   3. Zhang J,
   4. Shi Q,
   5. Song Z,
   6. Ding Z,
   7. Pang S, et al.

   Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet. 2009; 373: 2041–53.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   2. Corbelli J,
   3. Borrero S,
   4. Bonnema R,
   5. McNamara M,
   6. Kraemer K,
   7. Rubio D, et al.

   Use of the Gail model and breast cancer preventive therapy among three primary care specialties. J Womens Health (Larchmt). 2014; 23: 746–52.

   OpenUrlPubMed
8. 8.↵
   2. Yadav S,
   3. Hartkop S,
   4. Cardenas PY,
   5. Ladkany R,
   6. Halalau A,
   7. Shoichet S, et al.

   Utilization of a breast cancer risk assessment tool by internal medicine residents in a primary care clinic: impact of an educational program. BMC Cancer. 2019; 19: 228.

   OpenUrl
9. 9.↵
   2. Shams-White MM,
   3. Romaguera D,
   4. Mitrou P,
   5. Reedy J,
   6. Bender A,
   7. Brockton NT.

   Further guidance in implementing the standardized 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Score. Cancer Epidemiol Biomarkers Prev. 2020; 29: 889–94.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    2. Davidson NE,
    3. Armstrong SA,
    4. Coussens LM,
    5. Cruz-Correa MR,
    6. DeBerardinis RJ,
    7. Doroshow JH, et al.

    AACR Cancer Progress Report 2016. Clin Cancer Res. 2016; 22 Suppl 19: S1–37.

    OpenUrlFREE Full Text
11. 11.↵
    GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022; 400: 563–91.

    OpenUrlCrossRef
12. 12.↵
    2. Martinez-Jimenez F,
    3. Muinos F,
    4. Sentis I,
    5. Deu-Pons J,
    6. Reyes-Salazar I,
    7. Arnedo-Pac C, et al.

    A compendium of mutational cancer driver genes. Nat Rev Cancer. 2020; 20: 555–72.

    OpenUrlCrossRefPubMed
13. 13.↵
    2. Kuchenbaecker KB,
    3. Hopper JL,
    4. Barnes DR,
    5. Phillips KA,
    6. Mooij TM,
    7. Roos-Blom MJ, et al.

    Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017; 317: 2402–16.

    OpenUrlCrossRefPubMed
14. 14.↵
    2. Kushi LH,
    3. Doyle C,
    4. McCullough M,
    5. Rock CL,
    6. Demark-Wahnefried W,
    7. Bandera EV, et al.

    American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012; 62: 30–67.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    2. Chen X,
    3. Ding J,
    4. Li H,
    5. Carr PR,
    6. Hoffmeister M,
    7. Brenner H.

    The power of a healthy lifestyle for cancer prevention: the example of colorectal cancer. Cancer Biol Med. 2022; 19: 1586–97.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    2. Freisling H,
    3. Viallon V,
    4. Lennon H,
    5. Bagnardi V,
    6. Ricci C,
    7. Butterworth AS, et al.

    Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 2020; 18: 5.

    OpenUrlPubMed
17. 17.
    2. Pietzner M,
    3. Stewart ID,
    4. Raffler J,
    5. Khaw KT,
    6. Michelotti GA,
    7. Kastenmuller G, et al.

    Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med. 2021; 27: 471–9.

    OpenUrlPubMed
18. 18.↵
    2. Skou ST,
    3. Mair FS,
    4. Fortin M,
    5. Guthrie B,
    6. Nunes BP,
    7. Miranda JJ, et al.

    Multimorbidity. Nat Rev Dis Primers. 2022; 8: 48.

    OpenUrl
19. 19.↵
    2. Fang F,
    3. Fall K,
    4. Mittleman MA,
    5. Sparen P,
    6. Ye W,
    7. Adami HO, et al.

    Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med. 2012; 366: 1310–8.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    2. Kurisu K,
    3. Fujimori M,
    4. Harashima S,
    5. Akechi T,
    6. Matsuda T,
    7. Saika K, et al.

    Suicide, other externally caused injuries, and cardiovascular disease within 2 years after cancer diagnosis: a nationwide population-based study in Japan (J-SUPPORT 1902). Cancer Med. 2023; 12: 3442–51.

    OpenUrl